Yvonne L. Greenstreet

2021

In 2021, Yvonne L. Greenstreet earned a total compensation of $8.6M as President and Chief Operating Officer at Alnylam Pharmaceuticals, a 183% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$429,120
Option Awards$7,341,000
Salary$619,100
Other$186,000
Total$8,575,220

Greenstreet received $7.3M in option awards, accounting for 86% of the total pay in 2021.

Greenstreet also received $429.1K in non-equity incentive plan, $619.1K in salary and $186K in other compensation.

Rankings

In 2021, Yvonne L. Greenstreet's compensation ranked 1,316th out of 12,404 executives tracked by ExecPay. In other words, Greenstreet earned more than 89.4% of executives.

ClassificationRankingPercentile
All
1,316
out of 12,404
89th
Division
Manufacturing
467
out of 5,494
92nd
Major group
Chemicals And Allied Products
169
out of 2,369
93rd
Industry group
Drugs
141
out of 2,090
93rd
Industry
Pharmaceutical Preparations
92
out of 1,537
94th

Pay ratio

Yvonne L. Greenstreet's Pay$8,575,220
Median Employee's Pay$231,163
Pay Ratio

37

to 1

In 2021, the annual total compensation of Yvonne L. Greenstreet was $8,575,220.

The annual total compensation of the median employee at Alnylam Pharmaceuticals was $231,163.

The ratio of Yvonne L. Greenstreet's pay to the pay of median employee was therefore 37 to one.

Source: SEC filing on April 5, 2022.

Greenstreet's colleagues

We found four more compensation records of executives who worked with Yvonne L. Greenstreet at Alnylam Pharmaceuticals in 2021.

2021

John Maraganore

Alnylam Pharmaceuticals

Chief Executive Officer

2021

Tolga Tanguler

Alnylam Pharmaceuticals

Executive Vice President, Chief Commercial Officer

2021

Akshay Vaishnaw

Alnylam Pharmaceuticals

President, Research and Development

2021

Jeffrey Poulton

Alnylam Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like